Benoît Le Goff

ORCID: 0000-0002-4540-4549
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Shoulder Injury and Treatment
  • Spondyloarthritis Studies and Treatments
  • Musculoskeletal synovial abnormalities and treatments
  • Orthopedic Infections and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Spine and Intervertebral Disc Pathology
  • Orthopedic Surgery and Rehabilitation
  • Psoriasis: Treatment and Pathogenesis
  • Shoulder and Clavicle Injuries
  • Musculoskeletal pain and rehabilitation
  • Infectious Diseases and Tuberculosis
  • Tendon Structure and Treatment
  • Bone and Joint Diseases
  • Musculoskeletal Disorders and Rehabilitation
  • Cytokine Signaling Pathways and Interactions
  • Systemic Lupus Erythematosus Research
  • Osteomyelitis and Bone Disorders Research
  • Peripheral Nerve Disorders
  • Bone Metabolism and Diseases
  • Anesthesia and Pain Management
  • Hip disorders and treatments
  • Bone health and treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Inflammatory Myopathies and Dermatomyositis

Inserm
2015-2025

Nantes Université
2015-2025

Centre Hospitalier Universitaire de Nantes
2015-2024

Centre d'Investigation Clinique de Nantes
2012-2024

RMeS - Regenerative Medicine and Skeleton
2023-2024

Oniris
2023-2024

Hôtel-Dieu de Paris
2013-2023

Société Française de Rhumatologie
2017-2023

Hotel Dieu Hospital
2014-2022

Institut Régional de Médecine Physique et de Réadaptation
2021

Interleukin (IL)-36α, IL-36β and IL-36γ are expressed highly in skin involved the pathogenesis of psoriasis, while antagonists IL-36Ra or IL-38, another potential IL-36 inhibitor, limit uncontrolled inflammation. The expression role cytokines rheumatoid arthritis (RA) Crohn's disease (CD) is currently debated. Here, we observed that during imiquimod-induced mouse inflammation human IL-36α, γ IL-36Ra, but not IL-38 mRNA, was induced correlated with IL-1β T helper type 17 (Th17) (IL-17A,...

10.1111/cei.12761 article EN cc-by-nc Clinical & Experimental Immunology 2015-12-24

Objectives Interleukin (IL) 34 is a new cytokine implicated in macrophage differentiation and osteoclastogenesis. This study assessed IL-34 expression the tissue of patients with rheumatoid arthritis (RA). Methods Immunohistochemistry was performed synovial biopsies from RA (n=20), osteoarthritis (n=3) or other inflammatory (n=4). detected fluid by ELISA its messenger RNA studied quantitative PCR fibroblasts after stimulation tumour necrosis factor α (TNFα) IL-1β. Wild-type, jnk1 −/− –jnk2...

10.1136/annrheumdis-2011-200096 article EN Annals of the Rheumatic Diseases 2011-10-28

Interleukin (IL)-38 is a newly characterised cytokine that belongs to the IL-1 family. This expressed in rheumatoid arthritis (RA) synovial tissue and IL-38 deficient mice have exacerbated arthritis. Here, we analysed effect of overexpression joints arthritic mice, human macrophages fibroblasts vitro.Articular injections an adeno-associated virus (AAV) 2/8 encoding were performed collagen-induced (CIA), K/BxN serum transfer-induced (STIA) antigen-induced (AIA) mice. The was evaluated through...

10.1136/annrheumdis-2016-210630 article EN Annals of the Rheumatic Diseases 2017-03-13

We undertook this study to examine microRNA (miRNA) expression across rheumatoid arthritis (RA) phenotypes, along with the effects and mechanisms of action miRNA-17-5p (miR-17).A miRNA array was performed in synovial tissue biopsied from patients naive erosive RA (n = 3) nonerosive 3). MicroRNA-17 lipoplex delivered intraarticularly murine collagen-induced model. Clinical, histologic, structural were studied over course arthritis. In-depth studies miR-17 primary fibroblast-like synoviocytes...

10.1002/art.41441 article EN cc-by-nc Arthritis & Rheumatology 2020-07-19

Infliximab, an anti-tumour necrosis factor-α monoclonal antibody, is indicated in rheumatoid arthritis (RA). Our objective was to evaluate the influence of sources infliximab pharmacokinetic variability RA.Eighty-four patients treated with for RA were included a prospective noncomparative study. They analysed between two consecutive infusions. Infliximab concentrations measured before infusion, 2 h, 1 and 4 weeks after infusion immediately next infusion. described using two-compartment...

10.1111/bcp.12313 article EN British Journal of Clinical Pharmacology 2013-12-19

Proinflammatory macrophages and miR-155 are increased in patients with rheumatoid arthritis (RA). We studied membrane TNF (mTNF) expression on blood monocytes, polarization into macrophages, expression, the effect of anti-TNF these biomarkers RA patients. Sixty-seven 109 controls (55 healthy, 54 spondyloarthritis connective tissue diseases) were studied. Monocytes isolated differentiated or without anti-TNF. mTNF was monocytes from patients, but not other inflammatory diseases, correlated...

10.4049/jimmunol.1900386 article EN The Journal of Immunology 2019-09-04

Abstract RANK, RANK ligand (RANKL) and osteoprotegerin (OPG) are the key regulators of bone metabolism, both in normal pathological conditions. Previous data have demonstrated that human osteosarcoma biopsies express RANKL as well OPG, functional is expressed a murine cell line. As expression remains controversial, aim present study was to analyse its vitro lines, ex vivo using tissues, then determine functionality terms signal transduction pathways modulated by RANKL. RT‐PCR analysis...

10.1002/path.2140 article EN The Journal of Pathology 2007-02-26

Anticitrullinated peptide/protein antibodies (ACPA), which are highly specific for rheumatoid arthritis (RA), may be found in some patients with other systemic autoimmune diseases. The clinical significance of ACPA antisynthetase syndrome (ASS), a disease characterized by the association myositis, interstitial lung disease, polyarthralgia, and/or polyarthritis, has not yet been evaluated regard to phenotype, prognosis, and response treatment. ACPA-positive ASS were first identified among...

10.1097/md.0000000000000523 article EN cc-by-nc Medicine 2015-05-01

Macrophages and synovial fibroblasts (SF) are two major cells implicated in the pathogenesis of rheumatoid arthritis (RA). SF could be a source cytokines growth factors driving macrophages survival activation. Here, we studied effect on monocyte viability phenotype.SF were isolated from tissue RA patients CD14+ peripheral blood healthy donors. conditioned media collected after 24 hours culture with or without stimulation TNFα IL-1β. polarisation was by flow cytometry.Conditioned medium...

10.1155/2014/241840 article EN cc-by Mediators of Inflammation 2014-01-01
Coming Soon ...